Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 4
2006 4
2007 2
2008 2
2009 5
2010 2
2011 5
2012 4
2013 4
2014 4
2015 4
2016 3
2017 2
2018 3
2019 7
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Results by year
Filters applied: . Clear all
Page 1
Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.
Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y, Yamano Y. Sato T, et al. Among authors: Yagishita N. N Engl J Med. 2018 Feb 8;378(6):529-538. doi: 10.1056/NEJMoa1704827. N Engl J Med. 2018. PMID: 29414279 Free article. Clinical Trial.
The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq Approach.
Katsuya H, Islam S, Tan BJY, Ito J, Miyazato P, Matsuo M, Inada Y, Iwase SC, Uchiyama Y, Hata H, Sato T, Yagishita N, Araya N, Ueno T, Nosaka K, Tokunaga M, Yamagishi M, Watanabe T, Uchimaru K, Fujisawa JI, Utsunomiya A, Yamano Y, Satou Y. Katsuya H, et al. Among authors: Yagishita N. Cell Rep. 2019 Oct 15;29(3):724-735.e4. doi: 10.1016/j.celrep.2019.09.016. Cell Rep. 2019. PMID: 31618639 Free article.
Publisher Correction: Fgf10 is essential for limb and lung formation.
Sekine K, Ohuchi H, Fujiwara M, Yamasaki M, Yoshizawa T, Sato T, Yagishita N, Matsui D, Koga Y, Itoh N, Kato S. Sekine K, et al. Among authors: Yagishita N. Nat Genet. 2019 May;51(5):921. doi: 10.1038/s41588-019-0396-9. Nat Genet. 2019. PMID: 30948796
Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity.
Sato T, Yagishita N, Tamaki K, Inoue E, Hasegawa D, Nagasaka M, Suzuki H, Araya N, Coler-Reilly A, Hasegawa Y, Tsuboi Y, Takata A, Yamano Y. Sato T, et al. Among authors: Yagishita N. Front Microbiol. 2018 Jul 25;9:1651. doi: 10.3389/fmicb.2018.01651. eCollection 2018. Front Microbiol. 2018. PMID: 30090093 Free PMC article.
Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan.
Tsutsumi S, Sato T, Yagishita N, Yamauchi J, Araya N, Hasegawa D, Nagasaka M, Coler-Reilly ALG, Inoue E, Takata A, Yamano Y. Tsutsumi S, et al. Among authors: Yagishita N. Orphanet J Rare Dis. 2019 Oct 21;14(1):227. doi: 10.1186/s13023-019-1212-4. Orphanet J Rare Dis. 2019. PMID: 31639014 Free PMC article.
Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
Tamaki K, Sato T, Tsugawa J, Fujioka S, Yagishita N, Araya N, Yamauchi J, Coler-Reilly ALG, Nagasaka M, Hasegawa Y, Yamano Y, Tsuboi Y. Tamaki K, et al. Among authors: Yagishita N. Front Microbiol. 2019 Sep 11;10:2110. doi: 10.3389/fmicb.2019.02110. eCollection 2019. Front Microbiol. 2019. PMID: 31572323 Free PMC article.
[HTLV-1-associated myelopathy(HAM)].
Yamano Y, Araya N, Yagishita N, Sato T. Yamano Y, et al. Among authors: Yagishita N. Nihon Rinsho. 2015 Sep;73 Suppl 7:546-53. Nihon Rinsho. 2015. PMID: 26480757 Japanese. No abstract available.
National platform for Rare Diseases Data Registry of Japan.
Furusawa Y, Yamaguchi I, Yagishita N, Tanzawa K, Matsuda F, Yamano Y; RADDAR‐J Research and Development Group. Furusawa Y, et al. Among authors: Yagishita N. Learn Health Syst. 2019 Jan 31;3(3):e10080. doi: 10.1002/lrh2.10080. eCollection 2019 Jul. Learn Health Syst. 2019. PMID: 31317070 Free PMC article.
51 results
Jump to page
Feedback